34642898|t|In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI.
34642898|a|PURPOSE: Stroke is one of the most prevalent vascular diseases. Non-invasive molecular imaging methods have the potential to provide critical insights into the temporal dynamics and follow alterations of receptor expression and metabolism in ischemic stroke. The aim of this study was to assess the cannabinoid type 2 receptor (CB2R) levels in transient middle cerebral artery occlusion (tMCAO) mouse models at subacute stage using positron emission tomography (PET) with our novel tracer [18F]RoSMA-18-d6 and structural imaging by magnetic resonance imaging (MRI). PROCEDURES: Our recently developed CB2R PET tracer [18F]RoSMA-18-d6 was used for imaging neuroinflammation at 24 h after reperfusion in tMCAO mice. The RNA expression levels of CB2R and other inflammatory markers were analyzed by quantitative real-time polymerase chain reaction using brain tissues from tMCAO (1 h occlusion) and sham-operated mice. [18F]fluorodeoxyglucose (FDG) was included for evaluation of the cerebral metabolic rate of glucose (CMRglc). In addition, diffusion-weighted imaging and T2-weighted imaging were performed for anatomical reference and delineating the lesion in tMCAO mice. RESULTS: mRNA expressions of inflammatory markers TNF-alpha, Iba1, MMP9 and GFAP, CNR2 were increased to 1.3-2.5 fold at 24 h after reperfusion in the ipsilateral compared to contralateral hemisphere of tMCAO mice, while mRNA expression of the neuronal marker MAP-2 was markedly reduced to ca. 50 %. Reduced [18F]FDG uptake was observed in the ischemic striatum of tMCAO mouse brain at 24 h after reperfusion. Although higher activity of [18F]RoSMA-18-d6 in ex vivo biodistribution studies and higher standard uptake value ratio (SUVR) were detected in the ischemic ipsilateral compared to contralateral striatum in tMCAO mice, the in vivo specificity of [18F]RoSMA-18-d6 was confirmed only in the CB2R-rich spleen. CONCLUSIONS: This study revealed an increased [18F]RoSMA-18-d6 measure of CB2R and a reduced [18F]FDG measure of CMRglc in the ischemic striatum of tMCAO mice at subacute stage. [18F]RoSMA-18-d6 might be a promising PET tracer for detecting CB2R alterations in animal models of neuroinflammation without neuronal loss.
34642898	90	95	Mouse	Species	10090
34642898	105	122	Cerebral Ischemia	Disease	MESH:D002545
34642898	148	154	Stroke	Disease	MESH:D020521
34642898	184	201	vascular diseases	Disease	MESH:D014652
34642898	381	396	ischemic stroke	Disease	MESH:D002544
34642898	438	465	cannabinoid type 2 receptor	Gene	12802
34642898	467	471	CB2R	Gene	12802
34642898	493	525	middle cerebral artery occlusion	Disease	MESH:D020244
34642898	527	532	tMCAO	Disease	MESH:D020244
34642898	534	539	mouse	Species	10090
34642898	628	644	[18F]RoSMA-18-d6	Chemical	-
34642898	740	744	CB2R	Gene	12802
34642898	756	772	[18F]RoSMA-18-d6	Chemical	-
34642898	794	811	neuroinflammation	Disease	MESH:D000090862
34642898	841	846	tMCAO	Disease	MESH:D020244
34642898	847	851	mice	Species	10090
34642898	882	886	CB2R	Gene	12802
34642898	897	909	inflammatory	Disease	MESH:D007249
34642898	1009	1014	tMCAO	Disease	MESH:D020244
34642898	1049	1053	mice	Species	10090
34642898	1056	1078	18F]fluorodeoxyglucose	Chemical	MESH:D019788
34642898	1080	1083	FDG	Chemical	MESH:D019788
34642898	1147	1154	glucose	Chemical	MESH:D005947
34642898	1156	1162	CMRglc	Chemical	-
34642898	1299	1304	tMCAO	Disease	MESH:D020244
34642898	1305	1309	mice	Species	10090
34642898	1340	1352	inflammatory	Disease	MESH:D007249
34642898	1361	1370	TNF-alpha	Gene	21926
34642898	1372	1376	Iba1	Gene	114737
34642898	1378	1382	MMP9	Gene	17395
34642898	1387	1391	GFAP	Gene	14580
34642898	1393	1397	CNR2	Gene	12802
34642898	1514	1519	tMCAO	Disease	MESH:D020244
34642898	1520	1524	mice	Species	10090
34642898	1571	1576	MAP-2	Gene	17756
34642898	1619	1627	[18F]FDG	Chemical	-
34642898	1655	1663	ischemic	Disease	MESH:D002545
34642898	1676	1681	tMCAO	Disease	MESH:D020244
34642898	1682	1687	mouse	Species	10090
34642898	1749	1765	[18F]RoSMA-18-d6	Chemical	-
34642898	1868	1876	ischemic	Disease	MESH:D002545
34642898	1927	1932	tMCAO	Disease	MESH:D020244
34642898	1933	1937	mice	Species	10090
34642898	1966	1982	[18F]RoSMA-18-d6	Chemical	-
34642898	2009	2013	CB2R	Gene	12802
34642898	2073	2089	[18F]RoSMA-18-d6	Chemical	-
34642898	2101	2105	CB2R	Gene	12802
34642898	2120	2128	[18F]FDG	Chemical	-
34642898	2140	2146	CMRglc	Chemical	-
34642898	2154	2162	ischemic	Disease	MESH:D002545
34642898	2175	2180	tMCAO	Disease	MESH:D020244
34642898	2181	2185	mice	Species	10090
34642898	2205	2221	[18F]RoSMA-18-d6	Chemical	-
34642898	2268	2272	CB2R	Gene	12802
34642898	2305	2322	neuroinflammation	Disease	MESH:D000090862
34642898	2331	2344	neuronal loss	Disease	MESH:D009410
34642898	Negative_Correlation	MESH:D020244	17756
34642898	Positive_Correlation	MESH:D020244	17395
34642898	Association	MESH:D007249	12802
34642898	Association	MESH:D007249	114737
34642898	Association	MESH:D007249	17395
34642898	Association	MESH:D007249	14580
34642898	Positive_Correlation	MESH:D020244	114737
34642898	Association	MESH:D005947	MESH:D019788
34642898	Positive_Correlation	MESH:D020244	12802
34642898	Association	MESH:D007249	21926
34642898	Positive_Correlation	MESH:D020244	21926
34642898	Positive_Correlation	MESH:D020244	14580

